Novo Nordisk | NVO - Ingresos Por Ventas

Precio De Mercado
36.95
Cambio Diario
0.51 1.40%
Mensual
0.76%
Anual
-44.90%
Q2 Expectativa
34.18




Ventas Cambio Fecha
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Aurora Cannabis CAD 94.19M 3.82M 2025-12
Bausch Health Companies USD 2.8B 120M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Canopy Growth CAD 74.54M 7.86M 2025-12
Corcept Therapeutics USD 202.12M 5.48M 2025-12
Drreddys Laboratories INR 87.27B 1.82B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Merck USD 16.4B 880M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 13.86B 50M 2025-12
Novo Nordisk DKK 79.14B 4.16B 2025-12
Novo Nordisk DKK 12.53B 560M 2025-12
Pacira USD 196.87M 17.35M 2025-12
Perrigo USD 1.11B 70M 2025-12
Phibro Animal Health USD 373.91M 10.02M 2025-12
Prestige Brands USD 283.44M 9.34M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
Zoetis USD 2.4B 0 2025-12